KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial.

ESMO Open · 2026-Jun-25 · PMID 42349245

Panel Overall_survival_by_raised_baseline_tumour_markers提取失败待 EXE 对齐验证

overall survival

Figure 1 OS by raised baseline tumour markers. CA19-9, carbohydrate antigen 19-9; CA125, cancer antigen 125; CEA, carcinoembryonic antigen; OS, overall survival.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.00
质量通过否
预期曲线2
实际曲线0
X 范围-
Y 范围-
No curves extracted

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0failed待验证02026-07-18T18:59:09+00:00